Organovo Holdings Inc. News
Biotech Movers: Shire, Bellicum, Organovo
Shire, Bellicum Pharmaceuticals and Organovo Holdings were among the biotech stock movers in premarket trading on June 22.
Biotech Movers: Intra-Cellular Therapies, Organovo, Acorda
Intra-Cellular Therapies, Organovo Holdings and Acorda Therapeutics were among the biotech stock movers in premarket trading on Monday.
Biotech Movers: Organovo, Endo, Omeros
Organovo, Endo and Omeros were among the biotech stock moves in premarket trading on Thursday.
Neurocrine Biosciences Leads Pre-Market Biotech Movers
The company's shares were up 24% ahead of market's open on an FDA approval.
Immunomedics, Seattle Genetics lead biotech movers on deal news
The companies inked a $250 million deal on Friday that could be worth up to $2 billion, thanks to milestone payments.
Biotech premarket movers: Pacira, Clearside Biomedical and Organovo
Pacira Pharmaceuticals, Clearside Biomedical and Organovo Holdings are among the premarket biotech movers on Wednesday.
Biotech premarket movers: Amicus Therapeutics, Nantkwest, Organovo
Amicus Therapeutics, Nantkwest and Organovo are among the premarket biotech movers on Tuesday.
Organovo (onvo) stock drops on common stock offering
Organovo (ONVO) said on Thursday that it would sell 9 million shares of common stock at $2.75 per share in a public offering.
Organovo Holdings (ONVO) Stock: Weak On High Volume Today
Trade-Ideas LLC identified Organovo Holdings (ONVO) as a weak on high relative volume candidate
Breaking News
Samsung Sees Smaller Smartphone Market In 2023; Won't Cut Chip Spending Despite Demand Slump
“Amid prolonging geopolitical issues, continued inflation, and the continued economic slowdown, we expect the smartphone market to contract in 2023," said Samsung vice president Daniel Araujo.
UPS Earnings Top Street Forecasts On Margin Focus, Revenues Miss; New $5 Billion Share Buyback Unveiled
UPS topped Street forecasts for its fourth quarter earnings, but a slump in international deliveries kept revenue gain in check.
General Motors Earnings Blast Street Forecasts; Sees Robust 2023 Profits
GM blasted Street profit forecasts with adjusted earnings of $2.12 per share on revenues of $43.1 billion.
Ford Follows Tesla Into EV Price War With Mustang Mach-E Cuts, Production Boost
"We are not going to cede ground to anyone," said Marin Gjaja, COO for Ford Model e.